10
Clinical Trials associated with Insulin human biosimilar(Wockhardt Ltd.) / Not yet recruitingNot Applicable A RANDOMIZED, SINGLE CENTER, DOUBLE BLIND, TWO TREATMENT, TWO-PERIOD, CROSSOVER GLUCOSE CLAMP STUDY TO TEST FOR BIOEQUIVALENCE BETWEEN WOCKHARDTâ??S WOSULIN® 30/70 (100 IU/mL) {BIPHASIC ISOPHANE INSULIN INJECTION/ 70% HUMAN INSULIN ISOPHANE SUSPENSION AND 30% HUMAN INSULIN INJECTION (r-DNA ORIGIN)} AND HUMULIN® 70/30 (100 U/mL) {70% HUMAN INSULIN ISOPHANE SUSPENSION AND 30% HUMAN INSULIN INJECTION (rDNA origin)} IN HEALTHY SUBJECTS. - Clamp Study
/ RecruitingNot Applicable A RANDOMIZED, SINGLE CENTER, DOUBLE BLIND, TWO TREATMENT, TWO-SEQUENCE, TWO PERIOD, CROSSOVER GLUCOSE CLAMP STUDY TO TEST FOR BIOEQUIVALENCE BETWEEN WOCKHARDTâ??S WOSULIN® N (100 IU/mL) {ISOPHANE INSULIN HUMAN, SUSPENSION, r-DNA ORIGIN} AND HUMULIN® N (100 U/mL) {HUMAN INSULIN (r-DNA ORIGIN) ISOPHANE SUSPENSION}, IN HEALTHY SUBJECTS. - Clamp Study
/ TerminatedNot Applicable A double-blind, randomized, single dose, two-period, two-way crossover bioequivalence study between two Recombinant DNA human soluble Insulin Formulations - Wockhardtâ??s rDNA human regular Insulin Injection (Wosulin R) 100 IU/mL with Actrapid® HM Penfill® (Regular, Human Insulin injection [rDNA origin] IP) 100 IU/mL, 3.0 mL of Imported by: Novo Nordisk India Private Limited and Manufactured by: Novo Nordisk Producao Farmaceutica do Brasil Ltda. Brazil 39404004, INDIA in healthy, adult, male subjects under fasting condition. - PK PD Trial
100 Clinical Results associated with Insulin human biosimilar(Wockhardt Ltd.)
100 Translational Medicine associated with Insulin human biosimilar(Wockhardt Ltd.)
100 Patents (Medical) associated with Insulin human biosimilar(Wockhardt Ltd.)
100 Deals associated with Insulin human biosimilar(Wockhardt Ltd.)